According to the complaint, the potential damages at issue from the Opt-Out Plaintiffs equals approximately $4.2 billion.

Source: https://www.marketscreener.com/quote/stock/BAUSCH-HEALTH-COMPANIES-I-44965075/news/Attention-Bausch-Health-Companies-Inc-BHC-Shareholders-Kessler-Topaz-Meltzer-Check-LLP-Remind-44531692/?utm_medium=RSS&utm_content=20230805

He is coming at the issue from a unique vantage point.

Source: https://time.com/6246720/house-republicans-weaponization-panel-democrats-debate/

In the past the Tesla CEO has expressed support for psychedelics and tweeted in response to a thread on the issue from billionaire investor Marc Andressen.

Source: https://www.dailystar.co.uk/news/world-news/elon-musk-slams-new-2700-30201895

With the supply of Adderall being limited by the Drug Enforcement Agency, federal players are increasingly looking to address the issue from the top down.

Source: https://1010wcsi.com/fox-health/adderall-and-ozempic-are-in-the-spotlight-amid-widespread-drug-shortages-in-us/?utm_source=rss&utm_medium=rss&utm_campaign=adderall-and-ozempic-are-in-the-spotlight-amid-widespread-drug-shortages-in-us